スペインの地方政府は、健康保険医薬品代として2013年11月には、758'000'000ユーロ支払い2012年より4'8%%支払い増加、10月には5'2%増加、9月には9'8%増加。
El gasto farmacéutico encadena tres meses seguidos de subidas
El mercado de medicamentos absorbe las medidas de ahorro de los últimos Gobiernos
Emilio de Benito Madrid 2 ENE 2014 - 17:30 CET
Pharmaceutical expenditure chains three straight months of gains
The drug market absorbs saving measures recent governments
Emilio de Benito Madrid 2 ENE 2014 - 17:30 CET
Public spending on drug chains three straight monthly rise . The latest data , posted on the website of the Ministry of Health, for November . So the Administration ( the invoice is paid mostly autonomous communities ) was 758 million , up 4.8 % from a year earlier. In October, the increase was 5.2% , and 9.8% in September , although the latter figure suffered the perverse effect of diverting the medicamentazo purchases ( excluding over 400 drugs in public funding ) of a year earlier.
This sequence is confirmed that the drug market grows , after chaining 39 months of decline. Falls in absolute values began in June 2010 , with the reforms of the entry into force of the reference prices and rebates enacted by the government of José Luis Rodríguez Zapatero. Then it accelerated with the arrival of PP Government , to the exclusion of immigrants system and, above all , changing the copayment system which made pensioners paid first based on their income, which has fact that up to 16 % of the drugs prescribed to them have not been acquired , has denounced the opposition. He also contributed another twist to the reference price system and medicamentazo .
This time , coinciding with Christmas , Health has not even taken out a press release with the results. Back in July of this year stopped offering in their communications to -year comparison for the variation referred to two years earlier. This is still giving savings , although the figures pointed to the rebound finally been confirmed .
However , the drug market rise is natural : the new products are more expensive than the others, and the population ages. And these are the two key factors of this market. As a ministry spokeswoman Ana Mato directed when the first increases in spending , " we can not pretend that you always turn " came to light said . Another thing is if growth is to be maintained at acceptable levels (experts estimate that this would be about the CPI plus a spread ) , or whether it will reach 12 % which was about 10 years ago.
moreFarmaindustria believes that it can not save more recipesPharmaceutical expenditure grows despite copaymentThe PP claims that the repayment of drugs was a "claim of society"Health sets 42 copayment for hospital dispensing drugs
The Federation of Associations for the Defence of Public Health said , after analyzing the data , "the increase in spending is evident in recent months reflects a phenomenon that had already occurred in previous drug exclusions of public funding : displacement of prescription drugs continue to be funded and which are much more expensive . " They also criticized that " the sickest and with fewer resources , people can not access the medicines they need with health problems that would inevitably occur ."
The short-term forecasts are for a further increase , since, in theory, communities have to start over this month the system to collect hospital dispensing drugs (some for hepatitis, cancer), giving many free and, according to Health, should be subject to the same copayment than other products for chronic diseases.
Farmaindustria Meanwhile , employers Labs , predicts a slowdown in this game .
0 件のコメント:
コメントを投稿